Establishing tomorrow’s standard of care
What seems impossible today may be possible tomorrow
We develop for patients
For 40 years we have been committed to improve patient lives. With the heritage of our successful two standard-of-care therapies for prostate & colorectal cancer, we relentlessly aspire to identify and develop innovative treatments.
Cancer and antibiotic resistance are both critical health issues
Our pipeline reflects our commitment to provide solutions to unmet medical needs in oncology and infectious diseases.
What we look for
Small molecules, antibodies and peptides
From preclinical candidate to clinical phase I
Cancer therapies or antibiotics
Demonstrated mechanism of action
Preclinical efficacy data
Expertise in our oncology and infectious diseases
Late clinical development capabilities
Established sales force
Would like to partner with us? You have an interesting opportunity in oncology or bacterial infection? You would like to commercialize one of our products? Let's talk